🇸🇪 Cellolabs: We have raised $12 million in new funding
566
We are proud to share that we have raised $12M in new funding from Titian Life Sciences.
This investment is an important step in our ambition to make high-quality stem cells accessible and affordable at scale. It will support our international expansion and strengthen the infrastructure needed to bring stem cell science into real-world clinical use.
We are moving forward with a clear focus: shaping the next phase of regenerative medicine and setting a new global standard for stem cell access.
Originally published on 27 October by Cellolabs.
Announcements are published as a service to readers. The sender is responsible for all content.
Announcements for publication can be submitted to [email protected].
